(Q28369453)

English

Development of rifapentine susceptibility tests for Mycobacterium tuberculosis

scientific article

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Development of rifapentine susceptibility tests for Mycobacterium tuberculosis (English)

0 references

main subject

Mycobacterium tuberculosis

0 references

1 reference

L Heifets

1

0 references

T Sanchez

series ordinal

2

0 references

J Vanderkolk

series ordinal

3

0 references

V Pham

series ordinal

4

0 references

language of work or name

English

0 references

publication date

January 1999

0 references

published in

Antimicrobial Agents and Chemotherapy

0 references

volume

43

0 references

issue

1

0 references

page(s)

25-8

0 references

cites work

Comparison of activities of rifapentine and rifampin against Mycobacterium tuberculosis residing in human macrophages

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89015

retrieved

20 March 2017

Bactericidal activity in vitro of various rifamycins against Mycobacterium avium and Mycobacterium tuberculosis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89015

retrieved

20 March 2017

Activityin vitroof Rifabutin, FCE 22807, Rifapentine, and Rifampin againstMycobacterium microtiandM. tuberculosisand Their Penetration into Mouse Peritoneal Macrophages

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89015

retrieved

20 March 2017

Clinical mycobacteriology. Drug susceptibility testing

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89015

retrieved

29 September 2017

Effectiveness of clarithromycin and minocycline alone and in combination against experimental Mycobacterium leprae infection in mice

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89015

retrieved

29 September 2017

Antibacterial activity of DL 473, a new semisynthetic rifamycin derivative

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89015

retrieved

2 June 2018

Comparison of the sensitivity of mycobacteria to the cyclopentyl rifamycin DL473 and rifampicin

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89015

retrieved

2 June 2018

In-vitro antimycobacterial activity of rifapentine (comparison with rifampicin)

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89015

retrieved

2 June 2018

In vitro properties of rifapentine (MDL473) relevant to its use in intermittent chemotherapy of tuberculosis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89015

retrieved

2 June 2018

Uptake and activity of rifapentine in human peritoneal macrophages and polymorphonuclear leukocytes.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89015

retrieved

2 June 2018

Activity of two long-acting rifamycins, rifapentine and FCE 22807, in experimental murine tuberculosis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89015

retrieved

2 June 2018

[Activity of intermittently administered rifampicin and cyclopentyl rifamycin (or DL473) on experimental tuberculosis in the mouse]

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9869560

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

0 references

0 references

PubMed publication ID

9869560

0 references

(Q28369453)

Development of rifapentine susceptibility tests for Mycobacterium tuberculosis

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)